Evidence mapPaperPMID 40429997Full record

ReviewInternational journal of molecular sciences2025

Harnessing Mammalian- and Plant-Derived Exosomes for Drug Delivery: A Comparative Review.

Shynggys Sergazy, Sergazy Adekenov, Ilya Khabarov, Kymbat Adekenova, Assiya Maikenova, Mohamad Aljofan

Abstract readReviewComparative Study
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Exosome-like Nanoparticles Extracted from Plant Cells for Diabetes Therapy.International journal of molecular sciences · 2025
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shynggys SergazyResearch and Production Center Phytochemistry, Gazaliyev Street, Karaganda 100009, Kazakhstan.ORCID 0000-0002-6030-620X
Sergazy AdekenovResearch and Production Center Phytochemistry, Gazaliyev Street, Karaganda 100009, Kazakhstan.ORCID 0000-0001-7588-6174
Ilya KhabarovResearch and Production Center Phytochemistry, Gazaliyev Street, Karaganda 100009, Kazakhstan.
Kymbat AdekenovaResearch and Production Center Phytochemistry, Gazaliyev Street, Karaganda 100009, Kazakhstan.
Assiya MaikenovaResearch and Production Center Phytochemistry, Gazaliyev Street, Karaganda 100009, Kazakhstan.ORCID 0009-0005-6338-6099
Mohamad AljofanNational Laboratory Astana, Center for Life Sciences, Nazarbayev University, Astana 010000, Kazakhstan.

Funding

Nazarbayev University under Collaborative Research Program Grant OPCRP2025017Science Committee of the Ministry of Higher Education and Science of the Republic of Kazakhstan AP23489904
6 · The paper itself

Abstract

Exosomes, nanoscale vesicles involved in intercellular communication, have garnered significant attention for their potential in drug delivery and therapeutic applications. This review provides a comparative analysis of mammalian-derived exosomes, particularly milk-derived exosomes, and plant-derived exosome-like nanoparticles (PDENs). It explores their biogenesis, bioactivities, and functional similarities, including their roles in cellular communication, immune modulation, and disease therapy. While milk-derived exosomes exhibit promising biocompatibility and stability for targeted delivery, PDENs offer distinct advantages, such as scalability and inherent bioactivities, derived from their plant sources. Despite similarities in their structure and cargo, PDENs differ in lipid composition and protein profiles, reflecting plant-specific functions. Emerging research highlights the therapeutic potential of PDENs in managing inflammation, oxidative stress, and other diseases, emphasizing their utility as functional food components and nanocarriers. However, challenges related to their chemical stability and large-scale production require further investigation. This review underscores the need for advanced studies to fully harness the potential of these natural nanocarriers in drug-delivery systems and therapeutic interventions.

Indexed as

Drug Delivery SystemsExosomesPlantsAnimalsDrug CarriersHumansMilkNanoparticlesDrug Carriersdrug deliveryexosomesmammalian-derived extracellular vesiclesplant-based exosomes

Identifiers

PMID40429997
PMCPMC12112361

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.